INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 231 filers reported holding INOVIO PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.28 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $27,000 | -6.9% | 15,740 | 0.0% | 0.00% | – |
Q2 2022 | $29,000 | -53.2% | 15,740 | -8.7% | 0.00% | – |
Q1 2022 | $62,000 | -27.9% | 17,240 | 0.0% | 0.00% | – |
Q4 2021 | $86,000 | -31.2% | 17,240 | -1.1% | 0.00% | -100.0% |
Q3 2021 | $125,000 | -17.8% | 17,440 | +6.1% | 0.00% | 0.0% |
Q2 2021 | $152,000 | -6.2% | 16,440 | -5.7% | 0.00% | 0.0% |
Q1 2021 | $162,000 | +8.0% | 17,440 | +3.2% | 0.00% | 0.0% |
Q4 2020 | $150,000 | -22.7% | 16,900 | +1.0% | 0.00% | 0.0% |
Q3 2020 | $194,000 | -57.9% | 16,740 | -2.1% | 0.00% | -66.7% |
Q2 2020 | $461,000 | +290.7% | 17,105 | +26.7% | 0.00% | 0.0% |
Q1 2016 | $118,000 | +15.7% | 13,500 | -11.5% | 0.00% | 0.0% |
Q4 2015 | $102,000 | +15.9% | 15,250 | 0.0% | 0.00% | +50.0% |
Q3 2015 | $88,000 | -99.9% | 15,250 | -24.7% | 0.00% | -33.3% |
Q2 2015 | $165,240,000 | +49.1% | 20,250 | +80.0% | 0.00% | +50.0% |
Q3 2014 | $110,813,000 | -19.6% | 11,250 | -11.8% | 0.00% | -33.3% |
Q2 2014 | $137,828,000 | – | 12,750 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Green Alpha Advisors, LLC | 570,049 | $221,749 | 0.17% |
GMT CAPITAL CORP | 1,513,500 | $588,752 | 0.02% |
Cedar Brook Financial Partners, LLC | 130,522 | $50,773 | 0.01% |
Arlington Capital Management, Inc. | 27,735 | $10,789 | 0.01% |
GSA CAPITAL PARTNERS LLP | 296,948 | $116 | 0.01% |
Keystone Financial Group | 109,897 | $42,751 | 0.01% |
Hennion & Walsh Asset Management, Inc. | 163,562 | $63,626 | 0.00% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 1,149,974 | $447,340 | 0.00% |
Freedom Investment Management, Inc. | 62,298 | $24,234 | 0.00% |
Renaissance Technologies | 4,889,500 | $1,902 | 0.00% |